; (B) is consistent with the updated testing strategy required under section 211; (C) is coordinated with the State plan for COVID–19 testing prepared as required under the heading Department of Health and Human Services—Office of the Secretary—Public Health and Social Service Emergency Fund in title I of division B of the Paycheck Protection Program and Health Care Enhancement Act ( Public Law 116–139 ; 134 Stat. 620, 624); (D) is informed by contact tracing and surveillance activities under this subtitle; (E) is informed by guidelines established by the Centers for Disease Control and Prevention for which populations should be tested; (F) identifies how diagnostic and serological tests in such system shall be validated prior to use; (G) identifies how diagnostic and serological tests and testing supplies will be distributed to implement such system; (H) identifies specific strategies for ensuring testing capabilities and accessibility in medically underserved populations (as defined in section 330(b)(3) of the Public Health Service Act ( 42 U.S.C. 254b(b)(3) )), health professional shortage areas (as defined under section 332(a) of the Public Health Service Act ( 42 U.S.C. 254e(a) )), racial and ethnic minority populations, and geographically diverse areas, as determined by the Secretary; (I) identifies how testing may be used, and results may be reported, in both health care settings (such as hospitals, laboratories for moderate or high-complexity testing, pharmacies, mobile testing units, and community health centers) and non-health care settings (such as workplaces, schools, childcare centers, or drive-throughs); (J) allows for testing in sentinel surveillance programs, as appropriate